Financials
Financial year 2025
Worth noting
- A loss two years in a row.
- Little cash and receivables against the short-term debts.
Gross margin
€ -264,246
▲ 6% vs 2024
Profit
Caution€ -267,932
▲ 17% vs 2024
Debts
Normal€ 2.8 million
▲ 74% vs 2024
Genflow Biosciences from Charleroi, company number BE0753904685, closed financial year 2025 with a result of € -267,932 after tax. For that financial year Genflow Biosciences recorded a gross margin of € -264,246 and equity of € 896,515. Compared with financial year 2024, the result moved from € -324,575 to € -267,932. The company made a loss. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 31, 2026.
What happened at Genflow Biosciences?
What happened at Genflow Biosciences in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 267,933. Source: NBB ↗
- New establishment in Charleroi. KBO
- Eric Leire became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 318,366 loss in 2021 to € 267,933 loss in 2025.
A new publication or filing at Genflow Biosciences? We notify you, reason included.
Follow Genflow BiosciencesNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind Genflow Biosciences is Eric Leire.
Directors
According to the 2025 annual accounts
Eric Leire
Director
since 2020
Establishments
Establishment units
Physical locations of this company
Rue Auguste Piccard 48
6041 Charleroi
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 6 companies are registered at this address.
SYNABS
€ 742,551 gross margin · 2025
European Infrared Technologies
€ 53,354 gross margin · 2024
HEARTKINETICS
€ -463,720 gross margin · 2022
NEUVASQ BIOTECHNOLOGIES
€ 641,586 gross margin · 2025
CANCER STATE THERAPEUTICS
€ -105,252 gross margin · 2025
+1 more
Details
- Company number
- 0753.904.685
- VAT number
- BE 0753.904.685
- Registered office
- Rue Auguste Piccard 48, 6041 Charleroi
- Names & denominations
- Genflow Biosciences
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 10 September 2020
- Peppol
- Active · Active since 18 Mar 2025
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied